510(k) Report

510(k) · Cleared

Cleared

endomina system

K211309510(k) TraditionalCleared Dec 7, 2021221-day reviewClass II21 CFR 876.1500

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Endo Tools Therapeutics S.A. · OCW Endoscopic Tissue Approximation Device

Cleared on Dec 7, 2021 as substantially equivalent to K171886 (Apollo Endosurgery, Inc., 2017) after a 221-day review. Its family tree reaches back 4 generations to 1997. 1 later device descends from it.

Decided
Dec 7, 2021
Review
221 days
Class
Class II
Product code
OCW
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K972679 (1997). 7 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK972679 Endopath Endoscopic Tissue Fastening System (Etfs)Ethicon Endo-Surgery, Inc. · 1997
  2. 3 generations backK061770 Ethicon Endo Surgery Endoscopic Suturing SystemEthicon Endo-Surgery, Inc. · 2006
  3. 2 generations backK081853 Overstitch Endoscopic Suture SystemApollo Endosurgery, Inc. · 2008
  4. 1 generation backK171886 OverStitch SX Endoscopic Suturing System (ESS)Apollo Endosurgery, Inc. · 2017
  5. This deviceK211309 endomina systemEndo Tools Therapeutics S.A. · 2021
  6. Descendant · cites it directly · 0 of its ownK252400 Endomina EZFuse systemEndo Tools Therapeutics S.A. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K252400Endomina EZFuse systemEndo Tools Therapeutics S.A. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K972679Endopath Endoscopic Tissue Fastening System (Etfs)Ethicon Endo-Surgery, Inc.1997—
−3K061770Ethicon Endo Surgery Endoscopic Suturing SystemEthicon Endo-Surgery, Inc.2006—
−2K081853Overstitch Endoscopic Suture SystemApollo Endosurgery, Inc.2008—
−1K171886OverStitch SX Endoscopic Suturing System (ESS)Apollo Endosurgery, Inc.2017—
0 (this device)K211309endomina systemEndo Tools Therapeutics S.A.2021—
+1K252400Endomina EZFuse systemEndo Tools Therapeutics S.A.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200120

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K211309, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OCW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OCW device

  1. #1 K252400 Endomina EZFuse systemscore 12.0 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K171886OverStitch SX Endoscopic Suturing System (ESS)
Summary page 4
…y Class: Class II (21 CFR 876.1500) Product Code: OCW Predicate Device: K171886 – OverStitch™ Endoscopic Suturing System (Apollo Endosurgery) Device Descripti…
Apollo Endosurgery, Inc.2017—

Also cleared against K171886: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252400Endomina EZFuse systemEndo Tools Therapeutics S.A.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 9.0 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • Of its descendants, K252400 (Endo Tools Therapeutics S.A., 2026) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K171886.

How does its category compare?

All OCW devices

OCW Endoscopic Tissue Approximation Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · OCW

1in 2025

2007: 52008: 42009: 32010: 42011: 12012: 12013: 22016: 22017: 22018: 22019: 12020: 12021: 32023: 32025: 12026 (partial year): 2
2007high 5 (2007) · low 0 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OCW

133in 2023

2007: 58 days median2008: 70 days median2009: 30 days median2010: 91 days median2021: 221 days median2023: 133 days median
2007high 221 (2021) · low 30 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OCW

3so far in 2026, the most since 2007

2023: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OCW

326in 2025

2007: 92008: 472009: 302010: 102011: 162012: 282013: 22014: 282015: 592016: 742017: 4202018: 4132019: 2912020: 1832021: 1982022: 2352023: 2272024: 2112025: 326
2007high 420 (2017) · low 2 (2013)2025

MAUDE reports naming product code OCW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200755809
2008470047
2009330030
2010491010
20111—016
20121—028
20132—02
20140—028
20150—059
20162—074
20172—0420
20182—0413
20191—0291
20201—0183
202132210198
20220—0235
202331331227
20240—0211
20251—0326
20262—3—

What is it indicated for?

The endomina® system, composed of a triangulation platform (endomina® platform) and an instrument for tissue piercing and approximation (TAPES), is intended for endoscopic placement of suture(s) and approximation of soft tissue in the gastrointestinal tract. The system is to be used on an adult population.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K211309: endomina system.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K211309

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026